Literature DB >> 1827623

The treatment of precocious puberty.

M D Wheeler1, D M Styne.   

Abstract

Long-acting GnRH agonists are the treatment of choice for central precocious puberty. GnRH agonists are not effective in peripheral precocious puberty, but a number of other agents, including medroxyprogesterone acetate, ketoconazole, testolactone, and androgen antagonists, may be useful.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1827623

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  2 in total

Review 1.  Histrelin. A review of its pharmacological properties and therapeutic role in central precocious puberty.

Authors:  L B Barradell; D McTavish
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children.

Authors:  Xiaoping Luo; Ling Hou; Yan Zhong; Cheng You; Yu Yang; Xian Wu; Pin Li; Shasha Zhou; Wenjuan Qiu; Huiwen Zhang; Ying Liu; Ye Qian; Feihong Luo; Ruoqian Cheng; Yuhua Hu; Haihong Gong; Qing Wang; Zhuangjian Xu; Hongwei Du; Feiyu Lu; Junfen Fu; Xuefeng Chen; Winston Wang; Ziheng Guo
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.